Guy’s and St Thomas’ awarded £11.8m for Clinical Research Facility

Guy’s and St Thomas’ has been awarded £11.8m to allow it to continue providing the state-of-the-art facilities and staff needed to conduct ground-breaking experimental medicine studies.

The funding from the National Institute for Health Research (NIHR) was awarded following a competitive bidding process. Representing an increase on our 2017 award, it will support the Trust’s Clinical Research Facility (CRF) for five years from September 2022 and allows us to expand the amount of ground-breaking research undertaken across the Trust.

Our Clinical Research Facility is based in one of the largest NHS Trusts in the country, and we serve a diverse inner London population at four of our hospital sites, St Thomas’ Hospital and Evelina London (Lambeth), Guy’s Hospital (Southwark), and Royal Brompton Hospital (Chelsea). The new award supports our experimental medicine infrastructure across all these sites.

Our trials directly benefit patients, both immediately (participation giving access to new treatment opportunities), and longer term (through developing new standards of care to be delivered in the NHS).

We recruit more than 1 in 10 of all patients entering CRF trials nationally. Our research addresses a wide range of healthcare needs, from problems in the youngest children to diseases most common in the elderly. We specialise in trials testing new therapies and diagnostics for the first time in humans.

Find out more here.